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A B S T R A C T
The Quantiplex® Pro RGQ kit quantifies DNA in a sample, supports the detection of mixtures and assesses the
extent of DNA degradation based on relative ratios of amplified autosomal and male markers. Data show no
significant difference in the accuracy and sensitivity of quantification between this and the Promega
PowerQuant® System, both detecting the lowest amount of DNA tested, 4 pg. Laboratory controlled mixed
male:female DNA samples together with mock sexual assault samples were quantified across a range of mixture
ratios. Analysis software detected mixed DNA samples across all ratios for both quantification kits. Subsequent
STR analysis using the Investigator® 24Plex QS Kit was able to corroborate mixture detection down to 1:25
male:female DNA ratios, past which point mixtures appeared identical to single-source female samples. Analysis
software also detected laboratory degraded DNA samples, with data showing a positive trend between the
Degradation Index (DI) and length of time of sonication. When used on ancient remains the assay was able to
triage samples for further analysis, and STR profiles were concordant with DNA quantification results in all
instances. STR analyses of laboratory-controlled sensitivity, mixture, and degradation studies supports the
quality metric obtained from quantification. These data support the use of the Quantiplex® Pro RGQ kit for
sample screening and quantification in forensic casework and ancient DNA studies.
1. Introduction
In forensic analysis, the quantification of DNA recovered from a
crime scene sample is used to inform downstream processes such as STR
profiling [1]. Currently, the standard method for quantifying DNA from
forensic samples is quantitative PCR (qPCR), which monitors the am-
plification of specific regions of DNA by fluorophore excitation in real-
time [2]. By comparing the resulting fluorescent output to the signal
obtained from a series of DNA standards of known concentration, the
unknown sample(s) can be accurately quantified [3]. If a high con-
centration of DNA is recorded, the sample is diluted prior to use in the
STR amplification step. If a low concentration of DNA is recorded, DNA
can be concentrated down or a larger volume of the sample can be used
for STR amplification. By doing so, the DNA samples analysed should
match the recommended input concentrations based on the manu-
facturer’s instructions for the STR kit. Following these criteria, an in-
formative STR profile of good quality is generated. Early examples of
commercial qPCR kits include Quantifiler™ Duo (Applied Biosystems)
[4] and Plexor® HY (PROMEGA) [5], both of which quantify total au-
tosomal human and male (Y-specific) DNA to allow identification of
sex, putative identification of male:female mixtures and to facilitate the
quantification of male component for Y-STR testing. The use of such
qPCR kits forms an important part of the forensic workflow although
they do not always successfully detect degraded autosomal DNA sam-
ples and/or mixed male:female samples.
The detection of degraded autosomal DNA can be problematic at the
quantification step as the fragmentation of DNA causes a shift in the
ratio of high molecular weight (HMW) DNA to low molecular weight
(LMW) DNA [6] due to preferential degradation of larger DNA frag-
ments. As degradation increases the probability that the sample con-
tains an adequate amount of DNA of sufficient length for STR profiling
decreases [7]. Furthermore, quantification tends to underestimate the
true amount of DNA present [8] and simply increasing the amount of
this fragmented DNA in the STR amplification step may not result in an
STR profile. By identifying that the sample contains degraded DNA at
the quantification stage, forensic providers can select the most
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appropriate course of action, i.e. traditional STR profiling vs mini-STR
profiling or massively parallel sequencing [9]. The detection of mixed
male:female samples can also be complicated at the quantification step.
If the sample is of known female origin but shows male-specific DNA
amplification, it can be inferred that there is a male contributor present
in the female sample. However, mixture detection becomes more dif-
ficult if the sex of the sample donor is unknown, as under these con-
ditions a mixed male:female sample can look similar to a single source
male sample with imbalanced amplification of autosomal and male-
specific markers, an outcome observed when analysing low template
DNA samples due to stochastic amplification. By identifying that the
sample contains mixed male:female DNA at the quantification stage,
forensic providers can select the most appropriate course of action, i.e.
autosomal STR profiling vs Y-STR profiling. To support such decision
making, commercial qPCR kits such as the Quantifiler™ Trio (Applied
Biosystems) [10], PowerQuant® (PROMEGA) [11], and Quantiplex® Pro
(QIAGEN) [12] have been developed that can now detect degraded
autosomal DNA and/or mixed male:female samples [13].
One question that these current qPCR kits do not answer is whether
the male component in a mixed male:female sample is degraded, in-
stead giving a single autosomal measure of degradation. It becomes
important to understand the amount of degradation in each component
as such samples are common in sexual assault casework, where swabs
from a female victim may be taken weeks after the assault or be subject
to lengthy storage time prior to analysis [14]. To support analysis,
QIAGEN have recently developed the Quantiplex® Pro RGQ kit [15]
which assesses the quantity and quality of DNA through the amplifi-
cation of both long and short autosomal and male DNA fragments. In
this paper, we assess the performance of the Qiagen Quantiplex® Pro
RGQ kit by running a series of small validation studies following
SWGDAM guidelines [16]. Studies assessing accuracy, limit of detec-
tion, and capacity to detect sample mixtures and degraded DNA across
laboratory-controlled DNA samples were compared against the Pro-
mega PowerQuant® System [11]. In addition, the ability of the Quan-
tiplex® Pro RGQ kit to detect male:female mixtures from sexual assault
casework and degraded DNA extracted from ancient bone samples was
assessed. Representative samples quantified with the Quantiplex® Pro
RGQ kit were subject to STR analysis using the Qiagen Investigator®
24plex QS Kit [17] to verify quantification results.
2. Materials and methods
Four key validation parameters of the Quantiplex® Pro RGQ kit were
assessed: standard curve reproducibility, sensitivity, mixture analysis,
and degradation analysis. All of these parameters were compared
against the PowerQuant® System as a commercial equivalent using
control DNA of known concentrations under laboratory-controlled
conditions. A further two studies were performed using only the
Quantiplex® Pro RGQ kit that used casework samples for mixture and
degradation analysis. All DNA samples were either sourced commer-
cially or obtained from volunteers with ethical approval.
2.1. Quantification accuracy studies
The first set of studies assessed standard curve reproducibility and
sensitivity. Study one assessed the manufacturers’ claim that either a
four or seven point standard curve would provide reliable quantifica-
tion for both quantification kits. In this study, three independent re-
plicate standards curves were generated for each kit using four stan-
dards (Quantiplex standards – 50 ng/µL, 1.8519 ng/µL, 0.0686 ng/µL,
and 0.0025 ng/µL. PowerQuant standards – 50 ng/µL, 2 ng/µL,
0.08 ng/µL, 0.0032 ng/µL) and seven standards (Quantiplex standards –
50 ng/µL, 10 ng/µL, 2 ng/µL, 0.4 ng/µL, 0.08 ng/µL, 0.016 ng/µL, and
0.0032 ng/µL. PowerQuant standards – 50 ng/µL, 10 ng/µL, 2 ng/µL,
0.4 ng/µL, 0.08 ng/µL, 0.016 ng/µL, and 0.0032 ng/µL). Regression
analysis for each data set were performed, both within and between kits
and results compared between four and seven standards. Study two
assessed the quantification sensitivity of autosomal and Y-target DNA
by the Quantiplex® Pro RGQ, and PowerQuant® using commercially
sourced female and male DNA of known concentration (PROMEGA
Corporation; G1471 and G1521, respectively). Six independent re-
plicates at each input concentrations (250, 50, 10, and 2 pg/µL) were
quantified. Box-and-whisker plots were generated by comparing ob-
served quantification values against the expected quantification value.
2.2. Laboratory controlled mixture and degradation studies
This second set of studies used previously quantified volunteer DNA
to prepare a series of male:female mixtures and male degraded samples
from commercially-sourced DNA (PROMEGA Corporation G1521).
Study Three assessed the ability of Quantiplex® Pro RGQ and
PowerQuant® kits to detect male DNA contribution to a majority female
DNA sample. Using genomic male and female DNA at 0.5 ng/µL con-
centrations, male:female mixtures were prepared at 1:1, 1:25, 1:50
ratios. Unmixed male and female samples were also run at 0.5 ng/µL.
Three independent replicates at each mixture ratio were quantified with
both kits. Ratios of male:female DNA quantification values were cal-
culated and compared to the manufacturers default mixture detection
metrics (Quantiplex® Pro RGQ 1:2 Y:autosomal mixture flag;
PowerQuant® 1:2 Y:autosomal mixture flag). Study Four used DNA
degraded under laboratory controlled conditions. Male DNA was di-
luted to 5 ng/µL in amplification grade water in a total volume of
120 µL. This DNA sample was sonicated at 35 kHz for 30 min using a
Bandelin Sonorex RK 31 sonicator. Twelve microlitres of DNA was re-
moved from the sample prior to sonication (t = 0) and again at 1, 10
and 30 min into the sonication procedure. Degradation of samples was
confirmed by running 5 µL of sonicated DNA on a 2% TBE ethidium
bromide stained agarose gel. Degraded DNA samples were diluted to
0.25 ng/µL and 25 pg/µL and quantified using both kits. Ratios of HMW
and LMW DNA were calculated and compared against the manu-
facturers default Degradation Index (DI) metrics (Quantiplex® Pro RGQ
1:10 HMW:LMW degradation flag; PowerQuant® 1:2 HMW:LMW de-
gradation flag).
2.3. Mock casework mixture and degradation studies
Two additional studies were carried out using only the Quantiplex®
Pro RGQ kit. These studies used DNA extracted from mock casework
samples as an assessment of how the kit performs when using DNA
collected in the field. Study Five prepared mixed, mock sexual assault
samples by spiking male volunteer seminal fluid onto female volunteer
buccal swabs. Seminal samples and buccal swabs were collected fol-
lowing standard methods and were stored in the fridge overnight prior
to spiking. Three independent replicate samples were prepared for each
dilution series to represent a range of mixtures (neat seminal fluid at
50 µL, 5 µL, 1 µL, 0.1 µL spiked onto a female buccal swab). After
spiking, the swabs were subject to RSID testing [18] and DNA extrac-
tion was performed on the remaining solution using the DNeasy Blood
and Tissue kit (QIAGEN) [19] before undergoing quantification to as-
sess the kits ability to detect mixtures. Study Six assessed the utility of
the DI with ancient DNA (i.e. naturally degraded) samples obtained
from the Late Medieval (13th-15th century CE) archaeological site of
Poulton, located approximately eight km south of Chester (Cheshire,
UK) [20,21]. DNA extractions on nine samples were performed in
dedicated ancient DNA (aDNA) facilities at LJMU following previously
published protocols [22,23]. The cementum-rich root tip of the teeth
was sampled as it has been shown to preserve DNA better than most
types of bone [24–26]. Teeth were first cleaned with 1% sodium hy-
pochlorite and ddH2O, before using a multi-tool drill at the lowest
possible rpm (ca 100 rpm) to obtain ~75 mg tooth powder/sample. The
work surface (a dead-air fume cabinet) was thoroughly cleaned after
preparing each sample with one extraction blank included per seven
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human samples.
2.4. Quantification and STR analysis setup
All thermal cycling was carried out using a Rotor Gene Q 5Plex
HRM Instrument running Q-Rex Software v1.0 at 20 µL standard re-
action size. Reaction mixtures for both Quantiplex® Pro RGQ and
PowerQuant® kits were assembled according to manufacturer’s speci-
fications and contained 2 µL of either control DNA standard, sample
DNA, or amplification grade water as a negative control. Samples
processed with the Quantiplex® Pro RGQ kit used the manufacturers
recommended cycling and fluorescence acquisition settings as specified
in the technical manual and analysed according to the manufacturers
guidelines [27]. The PowerQuant® system was run using a custom
template file provided by the manufacturer (Promga Pers. Comm.) with
post-qPCR, raw sample data analysed using the Q-Rex Absolute Quan-
tification HID plug-in. PCR threshold values and threshold start cycles
were set according to manufacturer’s specifications. After analysis, all
kit data were exported from the Q-Rex software into Microsoft Excel to
prepare graphs and calculate mixture/degradation ratios.
STR profiling was performed using the Investigator® 24plex QS kit
[17] at 10 µL total PCR reaction volume. DNA from representative
samples of each study were added to each PCR reaction at the con-
centrations specified in the methods above. Thermal cycling was per-
formed according to the manufactures guidelines on a T100™ Thermal
Cycler (BIO-RAD). Capillary electrophoresis was performed using a
SeqStudio Genetic Analyser (Applied Biosystems). PCR samples were
prepared for analysis by mixing 1 µL of amplified DNA (diluted 1:10
with DNA-grade water) with 12 µL of a formamide and 0.5 µL DNA size
standard 24plex (BTO) mixture. Default instrument and quality control
protocol parameters for fragment analysis were used as recommended
by the Investigator® 24plex QS kit handbook [28] with a 7 s injection
time. Results were analysed in GeneMapper 6 software [29] with allele
calls generated automatically by a pre-optimised Investigator 24plex QS
allele bin panel. After data review, some samples were re-run with a
30 s injection time. Peak height data and allele calls for each locus was
tabulated and exported for analysis in Microsoft Excel.
3. Results & discussion
3.1. Quantification accuracy results
3.1.1. Study one
All standard curve data passed the acceptance criteria set by the
manufacturers [27] (Table 1). The Quantiplex® Pro RGQ and Power-
Quant® kits recommends the use of four DNA standards run in duplicate
to generate a standard curve for quantification. This is fewer than that
recommended by other kits [30,31] and may have a negative impact on
the linearity of the standard curve if one of the standards is incorrectly
prepared, causing a high leverage data point. Regression analysis using
Minitab 19.2 [32] showed no significant difference in the y-intercept
for the autosomal marker (P = 0.949), the male marker (P = 0.744),
and the autosomal degradation marker (P = 0.999) between each kit
when seven standards were used, suggesting that both kits are capable
of accurate quantification of both autosomal and male components.
Importantly, there were no significant differences in the y-intercept for
the autosomal marker (P = 0.961), the male marker (P = 0.983), the
autosomal degradation marker (P = 0.824) and the male degradation
marker (P = 0.9049) for the Quantiplex® Pro RGQ kit when either four
or seven standards were used, suggesting that four standards can be
used to generate a standard curve without reducing data quality.
Table 1
Amplicon size and standard curve metrics for Quantiplex® Pro RGQ and PowerQuant® kits.
Quantification Kit Marker and Amplicon Size
(bp)
Repeatability with Four Standards (Mean ± 1SD) Repeatability with Seven Standards (Mean ± 1SD)
Slope Intercept R2 Slope Intercept R2
Qiagen Quantiplex Pro RGQ Autosomal (91 bp) −3.25 ± 0.05 22.37 ± 0.20 0.99 ± 0.00 −3.32 ± 0.07 22.90 ± 0.07 0.99 ± 0.00
Male (81 bp) −3.28 ± 0.09 22.06 ± 0.32 0.99 ± 0.00 −3.32 ± 0.04 22.30 ± 0.10 0.99 ± 0.00
Auto Deg. (353 bp) −3.30 ± -0.17 21.65 ± 0.39 0.99 ± 0.00 −3.24 ± 0.13 22.97 ± 0.34 0.99 ± 0.00
Male Deg. (359 bp) −3.37 ± 0.07 21.17 ± 0.67 0.99 ± 0.00 −3.42 ± 0.13 22.05 ± 0.16 0.99 ± 0.00
Promega PowerQuant
System
Autosomal (84 bp) −3.31 ± 0.09 21.88 ± 0.03 0.99 ± 0.00 −3.31 ± 0.06 21.87 ± 0.06 0.99 ± 0.00
Male (81 & 136 bp) −3.03 ± 0.10 22.75 ± 0.08 0.99 ± 0.00 −3.06 ± 0.01 22.80 ± 0.06 0.99 ± 0.00
Auto Deg. (294 bp) −3.25 ± 0.07 22.74 + 0.22 0.99 ± 0.00 −3.26 ± 0.01 22.50 ± 0.34 0.99 ± 0.00
Fig. 1. A comparison of the accuracy of DNA quantification values against
decreasing DNA input amounts between the QIAGEN Quanitplex® Pro RGQ and
the PowerQuant® kits for autosomal DNA and male marker DNA. n = six for
each concentration.
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3.1.2. Study two
Quantification accuracy was assessed by calculating the difference
between the observed and expected quantification values across four
DNA input levels (Fig. 1). Both the PowerQuant® and Quantiplex® Pro
RGQ kits provide autosomal quantification values close to the expected
concentration of the standard. Compared to the PowerQuant® System,
the Quantiplex® Pro RGQ kit showed no significant difference in its
precision in quantifying both autosomal and male DNA at all but one of
the DNA input concentrations tested (F-Test autosomal DNA; 250 pg/
µL P = 0.2278, 50 pg/µL P = 0.1044, 10 pg/µL P = 0.0144, 2 pg/µL
P = 0.1021. F-Test male DNA; 250 pg/µL P = 0.1382, 50 pg/µL
P = 0.2367, 10 pg/µL P = 0.0822, 2 pg/µL P = 0.2657). The sig-
nificant difference in precision between kits observed when quantifying
10 pg/µL autosomal DNA is attributed to a single outlying data point
with the PowerQuant® system that underestimated DNA concentration.
As such, our data suggests that both kits perform broadly similar in
their ability to accurately quantify a given concentration of DNA tem-
plate across the ranges tested in this study. Sensitivity data from the
Quantiplex® Pro RGQ kit has been reported as low as 0.016 pg input
DNA [33], below the reported recommended dynamic range of
50 ng–0.5 pg total input DNA. While the data presented here cannot
confirm these detection limits, the data does demonstrate that the
Quantiplex® Pro RGQ kit is able to accurately quantify DNA within the
reported dynamic range, and performs similarly to the PowerQuant®
system as a commercial equivalent qPCR kit. Quantification results
were supported by STR data generated from both male and female
samples which show a trend for decreasing allele peak heights with
DNA input (Fig. 2). All alleles were observed in the 250 pg and 50 pg
input samples with instances of allelic dropout observed in 19 of the 24
loci at the 10 pg input level (Amelogenin, D3S1358, D21S11, CSF1PO
amplified) and 22 of the 24 loci at the 4 pg input level (Amelogenin
amplified). The failure to amplify alleles at such low input concentra-
tions are consistent with the manufacturer’s STR validation data [34]
again supporting the quantification results of the samples used in this
study.
3.2. Laboratory controlled mixture and degradation results
3.2.1. Study three
By quantifying autosomal and sex-linked PCR targets, it is possible
to infer the biological sex of whomever deposited a particular forensic
sample [3]. It can also support the detection of mixed DNA samples
where male DNA may be present in extremely small quantities against a
background of female-source DNA. Such samples may be encountered
in sexual assault casework where male seminal material may be col-
lected alongside female epithelial cells during examination. Such sam-
ples are usually subject to differential extraction to separate the male
and female fractions [35] or the entire sample is subject to Y-STR typing
[36]. Consequently, the ability to detect and quantify minor male
components in a larger female fraction is important to inform further
processing. Both kits were able to quantify autosomal and male DNA at
all mixtures tested and the autosomal:male (A:Y) ratios were calculated
(Fig. 3). All samples returned A:Y ratios within error of the expected
ratios. Statistical analysis shows no significant difference in the A:Y
ratios observed between kits at any mixture ratio (T-Test Male single-
source P = 0.19, Male:Female 1:1 P = 0.27, Male:Female 1:25
P = 0.29, Male:Female 1:50 P = 0.21), suggesting the kits are roughly
equal in performance when detecting mixtures.
STR analysis of laboratory mixed DNA samples show that ma-
jor:major mixtures were observed across all loci in male:female DNA
samples mixed at a 1:1 ratio concurring with the mixture detection
result from the quantification kit (Fig. 3). Furthermore, the allele bal-
ance between male and female mixtures suggests that the single source
samples were mixed in equal ratios prior to STR analysis. Major:Minor
mixtures were also observed at the 1:25 ratio, again supporting the
mixture detection result provided by the quantification with the minor
male contributor easily visible in loci with no neighbouring alleles.
Where loci had neighbouring alleles the minor male contributor alleles
were indistinguishable from stutter (Fig. 4). No mixed profiles were
observed at the 1:50 male:female mixture ratio despite the quantifica-
tion assay flagging the sample. The results suggest that there is a range
in which the Quantiplex Pro RGQ kit can predict the presence of mixed
STR profiles but past a certain ratio (1:25 observed in this study) there
will be preferential amplification of the major contributor leading to a
full, single source STR profile. However, as the mixture ratio reported
by the quantification kit is relatively accurate, careful interpretation of
the result should allow the forensic analyst to correctly predict the
occurrence of mixtures when moving on to STR amplification.
3.2.2. Study four
Several commercial qPCR kits contain multiple primer sets that co-
amplify both small and large DNA fragments to reflect the degradation
observed in the autosomal target [10–12]. Long DNA fragments are
known to be more susceptible to degradation than short fragments and
by calculating the ratio of long and short, a degradation index (DI) can
be generated that provides a measure of the integrity of DNA. A unique
Fig. 2. Allele peak heights for the smallest size range loci for each dye set observed across a DNA dilution series after amplification using Investigator 24plex QS Kit. *
Denotes instances of observed allelic dropout.
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feature of the Quantiplex® Pro RGQ kit is the inclusion of multiple
primer sets to identify degradation in both autosomal and Y targets. As
such, the kit may be of utility in laboratories that routinely analyse
degraded DNA samples. Under default analysis settings by proprietary
data analysis software, a Degradation Index (DI) value ≥ 10 (Quanti-
plex Pro RGQ) or ≥ 2 (PowerQuant®) is automatically identified as
possibly degraded. The data generated from the laboratory-controlled
degradation study for both Quantiplex® Pro RGQ and PowerQuant® kits
show that degradation indices increase with the duration of sonication
(Fig. 5). The sonicated samples displayed consistently higher DI values
for the male target using the Quantiplex® Pro RGQ kit, which would
infer that the male target is likely to be detected by the software as
being ‘degraded’ before the autosomal marker. One explanation for the
observed differences in detection is the relative size differences of the
autosomal and male targets (Table 1) which show an amplified frag-
ment length of 353 bp for the autosomal degradation marker and
359 bp for the male degradation marker. Size variation has been cited
as a possible reason for observed differences in degradation indices
Fig. 3. A comparison of the expected (Y-axis) and
observed (X-axis) quantification (ng/µL) ratios of
male:female DNA mixtures obtained when using the
Quantiplex® Pro RGQ and PowerQuant® kits.
n = three at each mixture ratio. Male DNA was not
quantified in the female single-source samples. Error
bars represent one standard deviation.
Fig. 4. Electropherogram of five representative loci amplified from various mixed DNA samples using the Investigator 24plex QS Kit. * Denotes instances of minor
contributor alleles in 1:25 mixtures; Δ denotes instances where minor contributor alleles cannot be differentiated from allelic stutter.
J. Morrison, et al. Science & Justice 60 (2020) 388–397
392
between kits [13] so may also explain the slight differences observed
here, although the 6 bp size difference seems unlikely to account for
such large differences in DI. Another possible explanation may be that
the primer used to amplify the male degradation marker may be less
efficient at amplification in the assay, consistently leading to fewer
copies of the large target being amplified and a bias in the relative
ratios. However, without the primer sequences being published this
cannot be verified.
At both 250 pg/µL and 25 pg/µL of DNA template, 10 min of so-
nication was enough to flag the male marker as potentially degraded
with the Quantiplex® Pro RGQ kit (Average DIs = 9.75 and 14.32 re-
spectively) whereas the autosomal markers remained below the de-
gradation detection threshold. All samples quantified by the
Quantiplex® Pro RGQ were flagged by the QIAGEN Data Handling Tool
as possibly degraded following 30 min of sonication. The PowerQuant®
technical manual recommends flagging [Auto]/[Degradation] ratios
of ≥ 2:1 as degraded, which is lower than the 10:1 ratio used by the
QIAGEN Data Handling Tool. At 250 pg/µL DNA input, autosomal DNA
was flagged as degraded using PowerQuant® settings at 10 and 30 min
of sonication, but would not have been flagged by the QIAGEN Data
Handling Tool (Average DIs = 3.53 and 4.23 respectively). This dis-
crepancy requires careful consideration by the forensic analyst using
these kits to avoid false positive and negative flagging of samples for
further processing and may require in-house optimisation based on
equipment and sample type. When using 25 pg/µL of template DNA,
degradation indices using the PowerQuant® kit were significantly
greater at 10 and 30 min compared to using 250 pg/µL input (T-Test
P = 0.006 and P = 0.03 respectively). This suggests that smaller
quantities of template are more prone to degradation, and that this
information will be captured during analysis. The range of autosomal
DI values reported in Fig. 3 are markedly lower than the average
Fig. 5. Degradation indices obtained from a time-course of sonicated male DNA run with QIAGEN Quantiplex® Pro RGQ Kit and PowerQuant® System.
A = Degradation indices of sonicated male DNA quantified using both kits at 250 pg/µL input. B = Degradation indices of sonicated male DNA quantified using both
kits at 25 pg/µL input. n = six at each time point. Error bars represent one standard deviation.
Fig. 6. Amplification success (%) for sonicated DNA at various time points. *
indicates instances where allelic dropout was observed; Δ indicates where locus
dropout was observed.
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autosomal DI values reported from previous research [13]. In the study
by Holmes, average DI values of ~58, ~75, and ~25 were reported for
bone, decomposed tissue and formalin-damaged tissue respectively
when using the alternative QIAGEN quantification kit, Quantiplex® Pro.
This suggests that the sonication approach used in our study could have
been performed over a longer time period to mimic the DI values re-
presentative of bone and degraded tissue. This said, the STR profiles
obtained from the laboratory degraded samples shows a decay curve
with the percentage of amplified loci decreasing with length of soni-
cation and, importantly, size of DNA fragment (Fig. 6). All alleles were
observed in un-sonicated samples across all fragment sizes, while
sample degraded for 1 min began to show allelic dropout for medium
(161–275 base pair) and large (304–428 base pair) fragment sizes. Al-
lelic dropout was also observed in the samples sonicated for 10 min and
30 min with whole loci (SE33, D21S11, D7S820) failing to amplify in
the large fragment size range (Fig. 6).
3.3. Mock casework mixture and degradation studies
3.3.1. Study five
The use of immunoassay tests to detect male seminal material is
common when processing sexual assault samples that may contain both
male and female biological fractions. Data from the male:female spiked
swabs show that the RSID test can detect the presence of seminal ma-
terial when spiked at 50 µL, 5 µL and 1 µL volumes but not at the 0.1 µL
(100 nL) volume. This is much less sensitive than previously reported
for the RSID test which shows seminal material being detected at the
2.5 nL volume [37]. The difference in reported limit of detection is
likely due to experimental differences between this study and others,
which often measure sensitivity based on a dilution series derived from
a single homogenised solution at a high starting concentration [37,38].
The method employed in the current study is considered a more rea-
listic approach to describe the sensitivity as the amount of seminal
material on the swab was varied before recovery. After the RSID test, the
remaining buffer solution underwent DNA extraction and quantifica-
tion where the average autosomal:male marker ratios were never less
that 2:1 (Fig. 7) meaning the QIAGEN Assay Data Handling Tool
flagged all mixtures.
The amplification of the male DNA target at the 0.1 µL semen spike
by the Quantiplex® Pro RGQ highlights an instance of non-concordance
between the two approaches and suggests that there may be instances
where male DNA from semen can be recovered after a negative RSID
result (Fig. 7). The amount of male DNA recovered from the 0.1 µL
semen spike was quantified at 1.1 pg/µL which is below the limit of
detection reported by many Y-STR kits [39,40] so it is debatable as to
whether the sample would yield an STR profile. Differences in detection
limits between immunoassay and PCR based approaches are common
and do not invalidate the use of such tests for sample prioritisation and/
or body fluid identification, and further testing on a larger number of
samples may be required to understand the extent to which non-con-
cordant results occur.
A mixed STR profile was observed after amplification using the
Investigator 24plex QS Kit at the 50 µL semen spike but not at the other
spike volumes (data nor shown) despite the quantification software
flagging all as possible mixtures. The results are broadly consistent with
those observed in the laboratory mixed samples in that over-dilution of
the male contributor will lead to non-amplification of male DNA. The
lack of a mixed STR profile in the 5 µL spike despite having an A:Y ratio
of 12.1 also highlights the stochastic nature of amplification at low
male contributor levels since only ~20 pg of male DNA was present in
Fig. 7. Detection of male material from spiked
swabs at four different semen volumes. Black
dashed line represents number of positive RSID
tests detecting semenogelin (right axis). Grey
bars represent concentration (ng/µL) of male
DNA obtained presented as log scale (left axis).
A:Y = average ratio of Autosomal to Y target
calculated after DNA quantification. Data sug-
gest that the qPCR approach is more sensitive
than the RSID test. n = three at each semen
volume. Error bars represent one standard de-
viation.
Table 2
Sample information relating to the sources of ancient DNA processed with the Quantiplex® Pro RGQ kit.
Sample ID Skeleton ID Type Year Excavated Sex Based on Osteological Identification Sex Based on DNA Quantification Sex Based on STR Profiling
Amelogenin DYS391
ASM8 847 Pre-molar 2016 Female Male Male (XY) Male
ASM10 854 Molar 2016 Female Female No Call No Call
ASM11 823 Incisor 2015 Not defined No DNA No Call No Call
ASM12 856 Pre-molar 2016 Not defined Female Female (X Call) No Call
ASM14 865 Canine 2016 Male Male Male (XY) Male
ASM17 873 Canine 2016 Not defined Female Female (X call) No Call
ASM18 797 Pre-molar 2015 Not defined Male Male (Y Allele) No Call
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this sample, whereas a major:minor mixture profile was observed in the
laboratory controlled samples at a higher mixture ratio 1:25 which also
included 20 pg male DNA. Together, the data from the SARC samples
suggest that the Quantiplex® Pro RGQ kit is capable of detecting mixed
samples across a range of ratios, although the extent to which this is
observed in the resulting STR profile will vary as a function of mixture
ratio and the amount of male contributor. Consequently, using the
mixture metric to accurately predict a mixture is likely possible with
Fig. 8. STR profiles obtained from ancient DNA samples post-PCR. Each profile contains sample information regarding autosomal and male DNA quantification,
degradation indices, and presence of sex alleles.
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each laboratory needing to set their own thresholds for interpretation
using laboratory controlled samples.
3.3.2. Study six
Prior to quantification of ancient DNA samples sourced from teeth,
osteological identification of skeletons was performed. The skeleton
number, year of excavation, and ostelogical sexing information for each
sample is displayed in Table 2. Of the nine ancient DNA samples, DNA
was quantified in six of them (no quantification values obtained for
ASM7, ASM11, and ASM15). For samples that amplified both autosomal
markers, higher autosomal DNA quantities were generally recorded for
samples with a lower autosomal DI (ASM8 and ASM14), while samples
with low autosomal DNA quantities showed a higher DI (ASM10 and
ASM12). According to the analysis software, the DI values for ASM15
and ASM18 were ‘not applicable’ due to the non-amplification of the
autosomal degradation marker, while no DI was given for ASM7 and
ASM11 due to the non-amplification of the autosomal marker. The
trend for high autosomal DNA concentrations returning low autosomal
DI scores was not observed in relation to the male markers, where the
sample ASM14 returned both a high male DNA concentration and a
high DI score. This result was due to very poor amplification of the male
degradation marker (calculated at 0.002 ng/µL). It is considered un-
likely that this result is due to contamination during sample processing
by staff as any contamination with recently shed, un-degraded DNA
would likely amplify both male and male-degradation markers equally.
It is considered more likely due to amplification imbalance between the
male marker and male degradation marker, either through different
amplification efficiencies of primers or stochastic DNA amplification.
Indeed, the results from sonicated male DNA samples at 500 pg and
50 pg show that the male DI is often much higher than the autosomal
DI, which is exacerbated in low template, degraded samples. The result
suggests that it may be common to observe single source male samples,
which have a low autosomal DI and a high male DI. Internal control Ct
values for all samples were far below the inhibition threshold value,
suggesting the results were not due to the presence of PCR inhibitors
and none of the samples were flagged as possible mixtures. Results from
the QIAGEN Data Handling Tool supports the osteological identification
of ASM14 as male as a relatively high quantification of ~300 pg/µL
male DNA was obtained. Additionally, no male DNA was detected in
sample ASM10, supporting the osteological identification of this sample
as female. However, male DNA quantities of ~200 pg/µL were observed
in sample ASM8, which had been osteologically identified as female.
With regards to samples with unknown osteological data, low
(< 30 pg/µL) male DNA was quantified in samples ASM7, ASM11,
ASM17, and ASM18. Lastly, no autosomal or male DNA was amplified
in sample ASM15, so no information about the sex of this individual
was obtained from this experiment. Although still widely used, osteo-
logical methods for sex identification are noted for their unreliability,
even with specialised computer software analysis tools [41]. Together,
the data suggest that the Quantiplex® Pro RGQ kit may be a useful tool
to support existing methods for determining sex in ancient remains and
for prioritising the best samples for further analysis, although it is
considered likely that a consensus result from multiple sample ob-
servations may be needed.
All samples underwent STR profiling (Fig. 8). STR amplification was
observed across a number of alleles with no evidence of contamination
from technical staff or mixtures observed between samples. Decay
curves were observed in the two samples that contained the most DNA
(ASM8, ASM14) with a reduction in relative peak height of the large
STR fragments. Some samples showed the complete non-amplification
of large STR fragments (ASM18, ASM10, ASM12) which correlated with
a higher DI or non-amplification of the DI marker during quantification.
Another sample (ASM17) showed a very low DI value and also a low
quantification value with stochastic amplification observed at a few loci
across the size range. Sample ASM11 did not provide any quantification
data (amount or DI) and also failed to provide an STR profile. Across all
samples, sex allele calls agreed with sample sexing based on quantifi-
cation results, in that Y-specific alleles were only present in samples
that quantified male DNA at any level. Together these results show
good evidence that the quantification results (DNA concentration and
DI) correlate well with the proceeding STR results suggesting that the
Quantiplex® Pro RGQ kit can aid in the prioritisation of samples for
further processing.
4. Summary
The data obtained from this series of experiments show that the
Quantiplex® Pro RGQ kit and PowerQuant® HY kit are similar in terms
of quantification accuracy and sensitivity against both autosomal and
male DNA targets. The detection of male:female mixtures from both
controlled DNA and mock samples suggest that the described kit may be
well suited to sexual assault casework where it is necessary to detect
low level male DNA in female samples. In addition, the DNA degrada-
tion data appear to determine DNA integrity in a reproducible manner
while data from ancient DNA samples provides supporting evidence
that the Quantiplex® Pro RGQ kit can aid identify samples for further
processing. In all instances, STR data was able to corroborate quanti-
fication results, although in the case of mixture detection the
Quantiplex® Pro RGQ kit provided evidence of minor:major mal-
e:female DNA mixtures where STR profiles returned a single-source
female DNA profile. This suggests that laboratories may need to vali-
date their own interpretation guidelines to fully utilise the information
provided by the quality metrics.
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